120 related articles for article (PubMed ID: 26304887)
21. A new tool in the medical bag shows promise.
Singhal S
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):804-5. PubMed ID: 26344684
[No Abstract] [Full Text] [Related]
22. [The prescription of serum tumor markers in a general hospital].
Watine J; Charet JC; Augé MC
Presse Med; 1998 May; 27(18):862, 864. PubMed ID: 9767874
[No Abstract] [Full Text] [Related]
23. Primary lung cancer producing alpha-fetoprotein.
Okunaka T; Kato H; Konaka C; Yamamoto H; Furukawa K
Ann Thorac Surg; 1992 Jan; 53(1):151-2. PubMed ID: 1370196
[TBL] [Abstract][Full Text] [Related]
24. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
25. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers in lung cancer.
Bearz A; Berretta M; Cappellani A; Lleshi A; Berto E; Fratino L; Tirelli U
Front Biosci (Elite Ed); 2010 Jun; 2(3):1099-104. PubMed ID: 20515780
[TBL] [Abstract][Full Text] [Related]
27. [Present Situation of Lung Cancer Screening Methods].
Zhang H; Zhang S
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):715-720. PubMed ID: 27760605
[TBL] [Abstract][Full Text] [Related]
28. High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer.
Choi IK; Kim YH; Kim JS; Seo JH
Acta Oncol; 2010 Aug; 49(6):861-4. PubMed ID: 20553098
[No Abstract] [Full Text] [Related]
29. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Alama A; Coco S; Vanni I; Grossi F
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629197
[TBL] [Abstract][Full Text] [Related]
30. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
31. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.
Chian CF; Hwang YT; Terng HJ; Lee SC; Chao TY; Chang H; Ho CL; Wu YY; Perng WC
Oncotarget; 2016 Aug; 7(31):50582-50595. PubMed ID: 27418131
[TBL] [Abstract][Full Text] [Related]
32. Development of a biosensor for electrochemical detection of tumor-associated proteins in blood plasma of cancer patients by aptamers.
Zamay GS; Zamay TN; Kolovskaya OS; Krat AV; Glazyrin YE; Dubinina AV; Zamay AS
Dokl Biochem Biophys; 2016; 466():70-3. PubMed ID: 27025492
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract][Full Text] [Related]
34. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer.
Wang DB; Lu XK; Zhang X; Li ZG; Li CX
Tumour Biol; 2016 Jan; 37(1):553-9. PubMed ID: 26232327
[TBL] [Abstract][Full Text] [Related]
36. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
37. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
[TBL] [Abstract][Full Text] [Related]
38. Liquid biopsy for early detection of lung cancer.
Hofman P
Curr Opin Oncol; 2017 Jan; 29(1):73-78. PubMed ID: 27906860
[TBL] [Abstract][Full Text] [Related]
39. Screening for lung cancer: Who should be screened?
Jett J
Arch Pathol Lab Med; 2012 Dec; 136(12):1511-4. PubMed ID: 23194043
[TBL] [Abstract][Full Text] [Related]
40. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
